BeOne Medicines AG Stock Forecast

Stock Price Forecast

According to 17 analysts polled by S&P Global, BeOne Medicines AG stock has a consensus rating of "Strong Buy" and an average price target of $253.16. The average 1-year stock price forecast is 36.25% higher than the current stock price, while the lowest is $212.43 (+14.33%) and the highest is $298.20 (+60.50%).

Price Target: $253.16 (+36.25%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$212.43	$253.16	$244.22	$298.20
Change	+14.33%	+36.25%	+31.44%	+60.50%

Analyst Ratings

The average analyst rating for BeOne Medicines AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	14	14	14	14	14	14
Buy	2	2	3	3	3	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	17	17	17	17

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Li Bank of America Securities	Bank of America Securities	Buy Maintains $243.80	Buy	Maintains	$243.80	+31.22%	May 21, 2026
Unknown Analyst Citic Securities No rating	Citic Securities	Buy Maintains $240.00 → $234.00	Buy	Maintains	$240.00 → $234.00	+25.94%	May 12, 2026
Unknown Analyst CMBC International No rating	CMBC International	Buy Maintains $278.85	Buy	Maintains	$278.85	+50.08%	May 11, 2026
Unknown Analyst Bank of China No rating	Bank of China	Buy Maintains $240.00	Buy	Maintains	$240.00	+29.17%	May 8, 2026
Unknown Analyst CICC No rating	CICC	Buy Maintains $250.00	Buy	Maintains	$250.00	+34.55%	May 8, 2026

More Analyst Ratings

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.